Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Neuro-Oncology
For a patient with glioblastoma also found to have a distant presumed meningioma with a location/size such that you would have otherwise recommended RT, would you offer concurrent treatment?
Related Questions
Would patients receiving targeted therapies be eligible for TTFields for brain metastases?
How do you manage a patient with suspected meningiomatosis?
What planning and dose constraints are you using for 5-fraction hypofractionated FRST for vestibular schwannoma?
In a patient with an R1 resection of a chordoma who has declined proton therapy, what alternative radiation modality would you recommend?
In light of Aizer et al. data presented at ASCO 2025, what is your threshold for offering SRS/SRT in patients with multiple brain metastases?
How will you select patients with brain metastases for TTFields?
Do you still recommend protons for grade 2 and grade 3 glioma, following the Soprano study results showing a survival detriment?
Do you routinely obtain a biopsy of a presumed meningioma prior to SRS to confirm grade 1?
In what circumstances would you consider use of IDH inhibitors in high-grade astrocytomas?
How do you balance short-term efficacy against increased low-grade toxicity and quality-of-life considerations for higher single-fraction regimens in recurrent glioma patients?
